Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
OctoPlus
OctoPlus
Activities:
Manufacturing
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Drug Delivery
Dr. Reddy’s Laboratories to acquire OctoPlus for €27.4m
Aims to build a research base in Leiden, The Netherlands
Manufacturing
OctoPlus signs agreement with pharma company to develop controlled release formulation
Of a therapeutic compound for local delivery into joints
Manufacturing
Octoplus extends drug delivery contract with Top-5 pharma company
Will combine product candidate with Octoplus PolyActive drug delivery technology
Research & Development
OctoPlus extends development agreement with ESBATech
For controlled release product for ophthalmic indications
Drug Delivery
OctoPlus appoints ceo
Jan Hendrik Egberts to replace Simon Sturge
Drug Delivery
OctoPlus signs controlled release technology deal with US firm
Will use PolyActive technology to develop compound
Drug Delivery
OctoPlus wins drug delivery contract expansion
Client will proceed with PolyActive technology evaluation
Subscribe now